{"DataElement":{"publicId":"5916911","version":"1","preferredName":"Treatment Cohort Study 10056 Cohort Step 2 Code","preferredDefinition":"The code that represents the information pertaining to step 2 protocol10056 in which subsets of a defined population are identified.","longName":"TX_COH_SDY_10056_STEP_2_CD","context":"Theradex","contextVersion":"1","DataElementConcept":{"publicId":"2497526","version":"1","preferredName":"Treatment Cohort Study","preferredDefinition":"Information pertaining to studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics.","longName":"TX_COHORT_STDY","context":"DCP","contextVersion":"1","ObjectClass":{"publicId":"2416951","version":"1","preferredName":"Therapy","preferredDefinition":"An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","longName":"C15368","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Therapy","conceptCode":"C15368","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"02DBEE3F-243E-103A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-12","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-10-12","modifiedBy":"ONEDATA","dateModified":"2005-10-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2497524","version":"1","preferredName":"Cohort Study","preferredDefinition":"Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics.","longName":"C15208","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cohort Study","conceptCode":"C15208","definition":"A research study that compares a particular outcome (such as lung cancer) in groups of individuals who are alike in many ways but differ by a certain characteristic (for example, female nurses who smoke compared with those who do not smoke).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"191BBE49-FC9E-4C77-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-21","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-07-21","modifiedBy":"ONEDATA","dateModified":"2006-07-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"191BBE49-FCAF-4C77-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-21","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-07-21","modifiedBy":"SOKKERL","dateModified":"2017-05-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5916909","version":"1","preferredName":"10056 Cohort Step 2 Code","preferredDefinition":"A group of individuals, identified by a common characteristic._A symbol or combination of symbols which is assigned to the members of a collection._A specific stage of progression through a sequential process.","longName":"5916909v1.0","context":"Theradex","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"200","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"TAC1","valueDescription":"TAC1: T-VEC intratumor 10E6 pfu d1 & 10E8 pfu d22,36,50,(opt d64); RT: 50 Gy in 25 fx over 5 wk start D8; Surg Resect 4 wk post-RT; Optional Post-op RT Boost: 16-20 Gy at 2 Gy/fx 3 wk post-op; Optl Adj Chemo (MD discretion) start 8-12 wk post T-VEC","ValueMeaning":{"publicId":"5916910","version":"1","preferredName":"TAC1: T-VEC intratumor 10E6 pfu d1 & 10E8 pfu d22,36,50,(opt d64); RT: 50 Gy in 25 fx over 5 wk start D8; Surg Resect 4 wk post-RT; Optional Post-op RT Boost: 16-20 Gy at 2 Gy/fx 3 wk post-op; Optl Adj Chemo (MD discretion) start 8-12 wk post T-VEC","longName":"5916910","preferredDefinition":"TAC1: T-VEC intratumor 10E6 pfu d1 & 10E8 pfu d22,36,50,(opt d64); RT: 50 Gy in 25 fx over 5 wk start D8; Surg Resect 4 wk post-RT; Optional Post-op RT Boost: 16-20 Gy at 2 Gy/fx 3 wk post-op; Optl Adj Chemo (MD discretion) start 8-12 wk post T-VEC","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"55B46654-E38F-5E5E-E053-F662850A670D","latestVersionIndicator":"Yes","beginDate":"2017-08-01","endDate":null,"createdBy":"MAESKEB","dateCreated":"2017-08-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"55B46654-E3A8-5E5E-E053-F662850A670D","beginDate":"2017-08-01","endDate":null,"createdBy":"MAESKEB","dateCreated":"2017-08-01","modifiedBy":"ONEDATA","dateModified":"2017-08-01","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"5916908","version":"1","preferredName":"Cohort Step Code","preferredDefinition":"A group of individuals, identified by a common characteristic.:A specific stage of progression through a sequential process.:A symbol or combination of symbols which is assigned to the members of a collection.","longName":"C61512:C48176:C25162","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cohort","conceptCode":"C61512","definition":"A group of individuals, identified by a common characteristic.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Step","conceptCode":"C48176","definition":"A specific stage of progression through a sequential process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Code","conceptCode":"C25162","definition":"A symbol or combination of symbols which is assigned to the members of a collection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"55B46654-E367-5E5E-E053-F662850A670D","latestVersionIndicator":"Yes","beginDate":"2017-08-01","endDate":null,"createdBy":"MAESKEB","dateCreated":"2017-08-01","modifiedBy":"ONEDATA","dateModified":"2017-08-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"THERADEX:Theradex Systems Inc","workflowStatus":"RELEASED","registrationStatus":"Application","id":"55B46654-E378-5E5E-E053-F662850A670D","latestVersionIndicator":"Yes","beginDate":"2017-08-01","endDate":null,"createdBy":"MAESKEB","dateCreated":"2017-08-01","modifiedBy":"MAESKEB","dateModified":"2017-08-01","changeDescription":"Curated for Protocol 10056. bsm","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"3876594","version":"1","longName":"Theradex","context":"Theradex","ClassificationSchemeItems":[{"publicId":"3876603","version":"1","longName":"Theradex - CTMS 3.14","context":"Theradex"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Please select the Cohort","type":"Preferred Question Text","description":"Please select the Cohort","url":null,"context":"Theradex"}],"origin":"THERADEX:Theradex Systems Inc","workflowStatus":"RELEASED","registrationStatus":"Application","id":"55B62667-0378-609D-E053-F662850AC7EB","latestVersionIndicator":"Yes","beginDate":"2017-08-01","endDate":null,"createdBy":"MAESKEB","dateCreated":"2017-08-01","modifiedBy":"SOKKERL","dateModified":"2018-11-21","changeDescription":"Curated for Protocol 10056. bsm","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}